Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Ambee Pharmaceuticals Revenue

Ambee Pharmaceuticals had revenue of 42.23M BDT in the quarter ending December 31, 2025, a decrease of -19.65%. This brings the company's revenue in the last twelve months to 183.57M, down -18.88% year-over-year. In the fiscal year ending June 30, 2025, Ambee Pharmaceuticals had annual revenue of 230.55M with 5.13% growth.

• Revenue (ttm): 183.57M
• Revenue Growth: -18.88%
• P/S Ratio: 9.94
• Revenue / Employee: 387.28K
• Employees: 474
• Market Cap: 1.82B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	230.55M	11.25M	5.13%
Jun 30, 2024	219.30M	21.21M	10.71%
Jun 30, 2023	198.10M	17.10M	9.45%
Jun 30, 2022	180.99M	82.02M	82.86%
Jun 30, 2021	98.98M	-186.33M	-65.31%